PremiumThe FlyRecursion Pharmaceuticals acquires full rights to hypophosphatasia drug REV102 Recursion Pharmaceuticals assumed with an Equal Weight at Morgan Stanley Largest borrow rate increases among liquid names PremiumThe FlyLargest borrow rate increases among liquid names Recursion Pharmaceuticals Announces Workforce Reduction Strategy Recursion Pharmaceuticals announces 20% workforce reduction PremiumThe FlyLargest borrow rate increases among liquid names Largest borrow rate increases among liquid names Recursion Pharmaceuticals Registers Shares for Resale